UNH CEO Acquires Shares via Dividend Equivalents
UNITEDHEALTH GROUP INC
Subscribe to track UNH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
UNH CEO Acquires Shares via Dividend Equivalents
Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low
Insider: Noel Timothy John Title: Chief Executive Officer, UHC | Relationship: Officer
Transaction: • Type: Grant (Dividend Equivalents) • Shares: 44.329 • Price: $0.00 • Value: $0 • Owned After: 9,330.668
Key Insight: Routine acquisition of dividend equivalents on existing restricted stock units. This is not an open market transaction and has no market signaling value.
Market Context: This is a standard corporate action for executives holding equity awards at a mega-cap company like UNH ($291.55B market cap). The transaction is negligible.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A UnitedHealth Group executive received a minor, non-cash acquisition of 44 shares as dividend equivalents on existing restricted stock units.
- Market Impact: Neutral. This is a routine, non-discretionary transaction with no market signaling value.
Company Information
| Field | Value |
|---|---|
| Company | UNITEDHEALTH GROUP INC |
| Ticker Symbol | UNH |
| CIK | 0000731766 |
| Industry | HOSPITAL & MEDICAL SERVICE PLANS |
Insider Information
| Field | Value |
|---|---|
| Name | Noel Timothy John |
| CIK | 0002053810 |
| Title/Position | Chief Executive Officer, UHC |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-16 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 44.329 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 9,330.668 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.000% |
| Shares Transacted | 44.329 |
| % of Shares Outstanding | <0.001% |
| Post-Transaction Ownership | 9,330.668 shares (0.001% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value is $0, making it immaterial for a company with a market capitalization of $291.55 billion.
- Ownership Concentration: The insider's total holdings of 0.001% of outstanding shares is negligible.
- Dilution Impact: The dilution from this grant is effectively zero.
- Transaction Significance: The transaction is a routine administrative event related to existing compensation and carries no investment signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a non-discretionary acquisition of dividend equivalents with a $0 value, not an open-market trade. It provides no new information about the insider's view of the company's prospects.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open market transaction.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnote clarifies these shares are dividend equivalents paid on outstanding restricted stock units, subject to the same vesting terms as the underlying award. This is not a purchase.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.